ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 91101 | ISO/PWI 20166-1 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for formalin-fixed and paraffin-embedded (FFPE) tissue — Part 1: Isolated RNA | Izstrādē |
| 90122 | ISO/AWI 21474-4 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 4: Detection of pathogens | Izstrādē |
| 90121 | ISO/WD 25379-2 | In vitro diagnostic Next Generation Sequencing (NGS) workflows — Part 2: Human RNA examination | Izstrādē |
| 90120 | ISO/WD 25379-1 | In vitro diagnostic Next Generation Sequencing (NGS) workflows — Part 1: Human DNA examination | Izstrādē |
| 66154 | ISO/WD 35001 | Laboratory biorisk management system — Requirements | Izstrādē |
| 91142 | ISO/AWI 15197 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Izstrādē |
| 31449 | ISO/WD 17593 | Specifications and standards for instruments for self testing in monitoring of anticoagulation treatment | Izstrādē |
| 86739 | ISO/WD TS 21385 | Guidance for emerging technologies intended for medical laboratory use | Izstrādē |
| 91317 | ISO/AWI TS 25725 | Design and workflow requirements for in vitro diagnostics NGS based oncology application | Izstrādē |
| 86743 | ISO/NP TS 20776-3 | ISO/TS 20776-3, Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — — Part 3: Part 3: Quality performance of disc-diffusion agar method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | Izstrādē |
Displaying 81-90 of 142 results.